MORPHINE LP EPIDURAL
MORPHINE LP EPIDURAL
Approved
DIN Number
02021056
Drug Class
Human
Market Date
Dec 31, 1993
Company
HC
Sandoz Canada, Inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02021056
AIG Number0104545007
Classification & Schedule
C
Drug Class
Human
S
Schedule
Narcotic (CDSA I)
A
ATC Code
N02AA01 MORPHINE
Product Specifications
Dosage FormSolution
Route of AdministrationEpidural
,
Intravenous
,
Subcutaneous
AHFS Classification28:08.08
Health Canada Classification
ACTIVE INGREDIENTS (1)
MORPHINE SULFATEActive
Strength: 0.5 MG / ML
Monograph: MORPHINE SULFATE